Literature DB >> 9719452

Frequency of Epstein-Barr virus-associated gastric adenocarcinoma in Taiwan.

L L Hsieh1, P J Lin, T C Chen, J T Ou.   

Abstract

Eighty-two gastric adenocarcinomas (32 intestinal and 50 diffuse type) were investigated for the presence of Epstein-Barr virus (EBV) DNA by amplifying the 78-bp fragment from the EBNA1 gene with polymerase chain reaction. EBV was detected in 17 (20.7%) of the 82 gastric tumorous specimens. Of these 17 EBV-positive cases, only one was EBV-positive in the adjacent non-tumorous tissue. EBV-positive gastric adenocarcinoma was present in 15.6 and 24.0% of the intestinal and diffuse type tumors, respectively, but within the two classes there was significant non-homogeneity by type. EBV was found more frequently in adenocarcinomas of the tubular (25%) and poorly differentiated (30.3%) types. EBV involvement was found more in male than in female patients. Eighty of the 82 tumors were also checked for the prevalence of p53 gene mutation. Of the 17 EBV-positive gastric adenocarcinomas, only two showed p53 gene mutations. The p53 mutation rate was lower in EBV-positive tumors (11.8%) than in EBV-negative tumors (25.4%).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9719452     DOI: 10.1016/s0304-3835(98)00111-6

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  9 in total

1.  Correlation of Epstein-Barr virus and its encoded proteins with Helicobacter pylori and expression of c-met and c-myc in gastric carcinoma.

Authors:  Bing Luo; Yun Wang; Xiao-Feng Wang; Yu Gao; Bao-Hua Huang; Peng Zhao
Journal:  World J Gastroenterol       Date:  2006-03-28       Impact factor: 5.742

2.  Epstein-Barr virus-associated gastric carcinoma in Kazakhstan.

Authors:  Gabit Alipov; Toshiyuki Nakayama; Masahiro Nakashima; Chun-Yang Wen; Daisuke Niino; Hisayoshi Kondo; Yuri Pruglo; Ichiro Sekine
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

3.  Four Decades of Prophylactic EBV Vaccine Research: A Systematic Review and Historical Perspective.

Authors:  Gabriela M Escalante; Lorraine Z Mutsvunguma; Murali Muniraju; Esther Rodriguez; Javier Gordon Ogembo
Journal:  Front Immunol       Date:  2022-04-14       Impact factor: 8.786

4.  Low expression of fibulin-1 correlates with unfavorable prognosis in gastric cancer.

Authors:  Liang Feng; Chan Yao; Peng Li; Ying Feng; Fei Wang; Yi-Fei Liu; Yi-Bing Guo; Qin-Sheng Mao; Wan-Jiang Xue
Journal:  Tumour Biol       Date:  2016-01-16

5.  Investigation of Epstein-Barr virus in Chinese colorectal tumors.

Authors:  Huan-Xin Liu; Yan-Qing Ding; Xin Li; Kai-Tai Yao
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

6.  High-throughput mutation profiling identifies frequent somatic mutations in advanced gastric adenocarcinoma.

Authors:  Jeeyun Lee; Paul van Hummelen; Christina Go; Emanuele Palescandolo; Jiryeon Jang; Ha Young Park; So Young Kang; Joon Oh Park; Won Ki Kang; Laura MacConaill; Kyoung-Mee Kim
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

7.  Detection of Epstein-Barr virus by PCR and expression of LMP1, p53, CD44 in gastric cancer.

Authors:  Myung Ah Lee; Young Seon Hong; Jin Hyoung Kang; Kyung Shik Lee; Jin Young You; Kyo Young Lee; Cho Hyun Park
Journal:  Korean J Intern Med       Date:  2004-03       Impact factor: 2.884

Review 8.  Epstein-Barr Virus and Gastric Cancer Risk: A Meta-analysis With Meta-regression of Case-control Studies.

Authors:  Jong-Myon Bae; Eun Hee Kim
Journal:  J Prev Med Public Health       Date:  2016-03-04

Review 9.  Epstein-Barr virus infection and gastric cancer: a systematic review.

Authors:  Xin-Zu Chen; Hongda Chen; Felipe A Castro; Jian-Kun Hu; Hermann Brenner
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.